AFX-0164

AFX-0164 is a marketed topical formulation developed by Afecta Pharmaceuticals for the management of acne-prone skin. The product utilizes Afecta's proprietary drug delivery technology to optimize the delivery of salicylic acid, a well-established keratolytic agent. By enhancing the solubility and skin penetration of the active ingredient, AFX-0164 is designed to provide effective comedolytic activity while minimizing the localized irritation and dryness often associated with traditional salicylic acid treatments. This formulation is part of Afecta's broader dermatology portfolio, which focuses on improving the therapeutic index of established dermatological agents through advanced delivery systems.